Biochemical risk factors for stone formation in a Scottish paediatric hospital population

Annals of Clinical Biochemistry

Volumn 47, Issue 2, 2010, Pages 125-130

  MacDougall, Lyndsey ^a   Taheri, Sepideh ^a   Crofton, Patricia ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CITRIC ACID; CREATININE; OXALIC ACID; URATE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEMATURIA; HUMAN; INFANT; INHERITANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEWBORN; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STONE FORMATION; URINALYSIS; URINARY EXCRETION;

CALCIUM; CALCIUM OXALATE; CALCIUM, DIETARY; CASE-CONTROL STUDIES; CHILD; CITRATES; CREATININE; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEMATURIA; HOSPITALS, PEDIATRIC; HUMANS; KIDNEY CALCULI; OXALATES; POPULATION GROUPS; RISK FACTORS; SCOTLAND; URIC ACID; URINARY CALCULI; UROLITHIASIS;

EID: 77749246605     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009146     Document Type: Article

References (29)

1. Henderson MJ. Renal stone disease - investigative aspects (Review). Arch Dis Child 1993;68:160-2
2. DeFoor W, Asplin J, Jackson E, et al. Urinary metabolic evaluations in normal and stone forming children. J Urol 2006;176:1793-6
3. Lama G, Carbone MG, Marrone N, Russo P, Spagnulo G. Promoters and inhibitors of calcium urolithiasis in children. Child Nephrol Urol 1990;10:81-4
4. Akcay T, Konukoglu D, Cigdem C. Hypocitraturia in patients with urolithiasis. Arch Dis Child 1996;74:351-1
5. Perrone HC, Toporovski J, Schor N. Urinary inhibitors of crystallization in hypercalciuric children with haematuria and nephrolithiasis. Pediatr Nephrol 1996;10:425-37
6. Akcay T, Konukoglu D, Dincer Y. Urinary glycosaminoglycans excretion in urolithiasis. Arch Dis Child 1999;80:271-2
7. Tekin A, Tekgü l S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 2000;164:162-5
8. Ratan SM, Bhatnagar V, Mitra DK, Basu N, Malhotra LK. Urinary citrate excretion in idiopathic nephrolithiasis. Ind Pediatr 2002;39:819- 25
9. Milosevic D, Batinic D, Konjevoda P, et al. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children. J Chem Inf Comput Sci 2003;43:1844-7
10. Baggio B, Gambaro G, Favaro S, et al. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors. J Urol 1983;130:1133-5
11. Batinic D, Milosevic D, Blau N, et al. Value of the urinary stone promoters/inhibitors ratios in the estimation of the risk of urolithiasis. J Chem Inf Comput Sci 2000;40:607-10
12. Batinic D, Milosevic D, Konjevoda P, et al. The value of urine citrate/ calcium ratio in the estimation of risk of urolithiasis. Clin Nephrol 2004;61:387-91
13. Berthelot M, Cornu G, Daudon M, Helbert M, Laurence C. Diffuse reflectance technique for infrared analysis of urinary calculi. Clin Chem 1987;33:780-3
14. Sugiura M, Yamamura H, Hirano K, et al. Enzymatic determination of serum oxalate. Clin Chim Acta 1980;105:393-9
15. de Jong JGN, Wevers RA, Liebrand-van Sambeek R. Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylene blue. Clin Chem 1992;38:803-7
16. Welshman SG, McCambridge H. The estimation of citrate in serum and urine using a citrate lyase technique. Clin Chim Acta 1973;46: 243-6
17. Harangi F, Gyorke Z, Melegh B. Urinary glycosaminoglycan excretion in healthy and stone-forming children. Pediatr Nephrol 1996;10:555-8
18. Bermudez JE. Bladder stone in a 3-year-old Dominican male. Mil Med 2002;167:698-700
19. Mortazavi F, Mahbubi L. Clinical features and risk factors of paediatric urolithiasis. Iran J Ped 2007;17:129-33
20. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-83
21. Kaneko K, Tsuchiya K, Kawamura R, et al. Low prevalence of hypercalciuria in Japanese children. Nephron 2002;91:439-43
22. Verkoelen CF. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? J Am Soc Nephrol 2006;17: 1673-87
23. Tekgü l S, Riedmiller H, Beurton D, et al. Guidelines on Paediatric Urology. European Society for Paediatric Urology and European Association of Urology, 2006
24. Sikora P, Bienias B, Majewski M, Borzecka H, Wawrzyszuk M, Zajaczkowska M. Urinary citrate excretion in children with calcium urolithiasis. Przegl Lek 2006;63:134-6
25. Yamaguchi S, Yoshioka T, Utsunomiya M, et al. Heparan sulphate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol Res 1993;21:187-92
26. Stone JE. Urine analysis in the diagnosis of mucopolysaccharide disorders. Ann Clin Biochem 1998;35:207-25
27. Harangi F, Gyorke Z, Melegh B. Urinary glycosaminoglycan excretion in urolithiasis. Arch Dis Child 2000;82:88
28. Tefekli A, Esen T, Ziylan O, et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 2003;70:273-7
29. Spivacow FR, Negri AL, del Valle EE, Calvino I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008;23:1129-33